ClinicalTrials HQ

Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies

Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies

Recruiting · NCT04959175 · Registry updated 2026-10-08
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic MalignanciesBronchiolitis Obliterans, Hemic and Lymphatic Diseases, Neoplasms by Site, bronchial disorder, bronchiolitis, bronchiolitis obliterans syndrome, bronchitis, cryptogenic organizing pneumonia, graft versus host disease, hematologic disorder, hematopoietic and lymphoid system neoplasm, immune system disorder, lung disorder, neoplasm, obstructive lung disease, respiratory system disorderRecruitingPhase 1 / Phase 22026-10-08NCT04959175

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
National Cancer Institute (NCI)3015

2 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Hospital of the University of PennsylvaniaPhiladelphiaUnited States142
National Institutes of Health Clinical CenterBethesdaUnited States800